Blueprint Medicines Corporation logo
Blueprint Medicines Corporation BPMC

Quartalsbericht 2025-Q1
hinzugefügt 01.05.2025

report update icon

Blueprint Medicines Corporation Current Ratio 2011-2026 | BPMC

Current Ratio Jährlich Blueprint Medicines Corporation

2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
1.34 1.14 1.62 4.45 6.92 4.85 8.29 16 7.73 9.14 - - - -

Alle Zahlen in USD-Währung

Indikatorenreichweite aus Jahresberichten

Höchstwert Mindestwert Durchschnitt
16 1.14 6.15

Current Ratio Vierteljährlich Blueprint Medicines Corporation

2025-Q1 2024-Q4 2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
1.4 1.34 1.35 1.36 1.43 1.14 1.22 1.39 1.51 1.62 1.78 - 4.37 4.45 6.42 6.54 7.21 6.92 6.92 6.92 6.92 2.91 2.91 2.91 2.91 4.46 4.46 4.46 4.46 7.8 7.8 - - - - - - - - - - - - - - - - - - - - - - - - - -

Alle Zahlen in USD-Währung

Indikatorspanne aus vierteljährlicher Berichterstattung

Höchstwert Mindestwert Durchschnitt
7.8 1.14 3.91

Current Ratio anderer Aktien in der Pharmaeinzelhändler

Name Current Ratio Preis % 24h Marktkapitalisierung Land
MorphoSys AG MorphoSys AG
MOR
1.02 - 2.43 % $ 254 M germanyGermany
Graybug Vision Graybug Vision
GRAY
0.672 - -11.23 % $ 9.65 M usaUSA
Apellis Pharmaceuticals Apellis Pharmaceuticals
APLS
1.52 $ 19.87 -1.44 % $ 2.51 B usaUSA
Aptorum Group Limited Aptorum Group Limited
APM
3.71 $ 0.82 3.61 % $ 4.47 M chinaChina
I-Mab I-Mab
IMAB
8.96 - - $ 866 M chinaChina
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
3.59 - - $ 40.3 B usaUSA
Acer Therapeutics Acer Therapeutics
ACER
0.41 - 2.71 % $ 14 M usaUSA
Biophytis SA Biophytis SA
BPTS
1.34 - -13.47 % $ 169 M franceFrance
Ampio Pharmaceuticals Ampio Pharmaceuticals
AMPE
2.41 - -11.43 % $ 502 K usaUSA
AbCellera Biologics AbCellera Biologics
ABCL
3.48 $ 3.66 -1.43 % $ 1.09 B canadaCanada
Athersys Athersys
ATHX
2.38 - 3.77 % $ 22.4 M usaUSA
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
1.02 - -1.52 % $ 24.7 M usaUSA
Midatech Pharma plc Midatech Pharma plc
MTP
2.29 - -18.52 % $ 27.3 M britainBritain
AVEO Pharmaceuticals AVEO Pharmaceuticals
AVEO
1.77 - - $ 521 M usaUSA
Axsome Therapeutics Axsome Therapeutics
AXSM
1.15 $ 163.94 -0.07 % $ 8.16 B usaUSA
Brainstorm Cell Therapeutics Brainstorm Cell Therapeutics
BCLI
0.191 - -2.5 % $ 5.88 M usaUSA
BioDelivery Sciences International BioDelivery Sciences International
BDSI
2.37 - -4.8 % $ 255 M usaUSA
Burford Capital Limited Burford Capital Limited
BUR
2.14 $ 8.43 -1.4 % $ 1.39 B britainBritain
BridgeBio Pharma BridgeBio Pharma
BBIO
0.311 $ 65.12 0.91 % $ 12.5 B usaUSA
Adverum Biotechnologies Adverum Biotechnologies
ADVM
1.65 - - $ 86.2 M usaUSA
CymaBay Therapeutics CymaBay Therapeutics
CBAY
3.05 - - $ 3.45 B usaUSA
Институт стволовых клеток человека Институт стволовых клеток человека
ISKJ
1.04 - - - russiaRussia
Avid Bioservices Avid Bioservices
CDMO
1.22 - - $ 789 M usaUSA
ARCA biopharma ARCA biopharma
ABIO
28.7 - 1052.0 % $ 415 M usaUSA
BioMarin Pharmaceutical BioMarin Pharmaceutical
BMRN
5.04 $ 59.06 0.91 % $ 11.3 B usaUSA
Checkpoint Therapeutics Checkpoint Therapeutics
CKPT
0.372 - - $ 169 M usaUSA
Caladrius Biosciences Caladrius Biosciences
CLBS
6.16 - -16.75 % $ 25.8 M usaUSA
Alpine Immune Sciences Alpine Immune Sciences
ALPN
2.67 - - $ 2.17 B usaUSA
Clovis Oncology Clovis Oncology
CLVS
0.629 - -7.23 % $ 13 M usaUSA
Acorda Therapeutics Acorda Therapeutics
ACOR
1.61 - -24.86 % $ 820 K usaUSA
Checkmate Pharmaceuticals Checkmate Pharmaceuticals
CMPI
8.41 - - $ 231 M usaUSA
Acasti Pharma Acasti Pharma
ACST
13.4 - 4.01 % $ 150 M canadaCanada
CTI BioPharma Corp. CTI BioPharma Corp.
CTIC
0.878 - - $ 1.2 B usaUSA
CohBar CohBar
CWBR
15.8 - -15.44 % $ 2.2 M usaUSA
Cyclacel Pharmaceuticals Cyclacel Pharmaceuticals
CYCC
0.653 - -5.98 % $ 34.1 M usaUSA
Cyclacel Pharmaceuticals Cyclacel Pharmaceuticals
CYCCP
0.653 - -4.36 % $ 27 M usaUSA
Deciphera Pharmaceuticals Deciphera Pharmaceuticals
DCPH
3.86 - - $ 2.18 B usaUSA
Cabaletta Bio Cabaletta Bio
CABA
14.5 $ 3.25 0.03 % $ 3.8 M usaUSA
Capricor Therapeutics Capricor Therapeutics
CAPR
1.63 $ 25.35 -1.92 % $ 679 M usaUSA
CureVac N.V. CureVac N.V.
CVAC
2.47 - - $ 867 M germanyGermany
Aeterna Zentaris Aeterna Zentaris
AEZS
1.6 - 5.93 % $ 314 M canadaCanada
Codexis Codexis
CDXS
1.82 $ 0.97 -1.14 % $ 71.2 M usaUSA
Corvus Pharmaceuticals Corvus Pharmaceuticals
CRVS
6.63 $ 17.25 -1.6 % $ 828 M usaUSA
AgeX Therapeutics AgeX Therapeutics
AGE
1.81 - -10.17 % $ 12.2 K usaUSA
Certara Certara
CERT
3.15 $ 7.44 2.69 % $ 1.19 B usaUSA
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
12.4 - - $ 1.01 B usaUSA
Coherus BioSciences Coherus BioSciences
CHRS
0.765 $ 1.71 3.33 % $ 161 M usaUSA
Entasis Therapeutics Holdings Entasis Therapeutics Holdings
ETTX
4.22 - - $ 105 M usaUSA
Evofem Biosciences Evofem Biosciences
EVFM
0.146 - 7.55 % $ 38.1 M usaUSA
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
1.79 - - $ 26.5 M usaUSA